CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-08 | GLUCK FREDERICK W Director | Gift | −3,900 | 237,015 | ||
| 2019-04-08 | GLUCK FREDERICK W Director | Gift | −3,900 | 267,743 | ||
| 2019-04-08 | GLUCK FREDERICK W Director | Gift | −3,900 | 18,211 | ||
| 2019-03-04 | ROWLAND LLOYD A General Counsel | Purchase | +9,000 | $10.33 | $93K | 9,979 |
| 2019-01-25 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2019-01-25 | HUMPHREY RACHEL Chief Medical Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2019-01-25 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (right to buy) | +54,900 | 54,900 | ||
| 2019-01-25 | RAY DEBANJAN Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2019-01-25 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2018-12-20 | Meyers James R Director | Grant or award · Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2018-12-12 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.45 | $4K | 8,928 |
| 2018-12-12 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $15.00 | $45K | 5,928 |
| 2018-12-12 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 7,220 | ||
| 2018-11-30 | McCarthy Sean A. President and CEO | Grant or award | +468 | $11.73 | $5K | 82,531 |
| 2018-11-30 | ROWLAND LLOYD A General Counsel | Grant or award | +979 | $11.73 | $11K | 979 |
| 2018-11-02 | McCarthy Sean A. President and CEO | Option exercise | +1,156 | $1.57 | $2K | 83,219 |
| 2018-11-02 | McCarthy Sean A. President and CEO | Sale | −1,156 | $15.01 | $17K | 82,063 |
| 2018-11-02 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −1,156 | 136,071 | ||
| 2018-11-01 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.45 | $4K | 8,928 |
| 2018-11-01 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $15.00 | $45K | 5,928 |
Page 16 of 33 · 649 trades